Re: Keytone Symposium on Respiratory Viruses of Animals Causing Disease in Humans
Re: Keytone Symposium on Respiratory Viruses of Animals Causing Disease in Humans
Will be there...
Khaw Boon Wan, Minister of Health, Singapore
Albert D.M.E. Osterhaus, Erasmus MC, Rotterdam, Holland
Animals and Human Respiratory Virus Infections
Roy M. Anderson, Imperial College, St. Mary's Medical School, London, UK
Dynamics of Respiratory Virus Infection
David L. Smith?, National Institutes of Health, Bethesda, USA
Dynamics of Vector Transmission
Derek Smith, Cambridge University, Cambridge, UK
Evolution of Influenza Viruses
Scott Dowell, Global Health CDC, Atlanta, USA
The Epidemiology of Human Infections with Influenza A (H5N1)
Robert G. Webster, St. Jude Children's Research Hospital, USA
The Reservoirs of Avian Influenza Viruses
Ming Liao, South China Agricultural University, China
Genetic Characterization of Influenza A (H5N1) Viruses in Birds
Chang Won Lee, United States Department of Agriculture, Athens, USA
Low and high pathogenicity avian influenza in Korea
Menno de Jong, Hospital for Tropical Diseases, Ho Chi Minh City, Viet Nam
Pathogenesis of Influenza A (H5N1) H5N1 in Humans
Jacqueline M. Katz, Centers for Disease Control and Prevention, Atlanta, USA
Epidemiology of Influenza A (H5N1) in Animals and Humans
Ron A.M. Fouchier, Erasmus MC, Rotterdam, Holland
Adaptation of Influenza A (H5N1) to Mammals
Guan Yi, Hong Kong University
Influenza A (H5N1) Virus in Asian Birds
Inger Damon, Centers for Disease Control and Prevention, Atlanta, USA
Monkeypox in Humans
Koert Stittelaar, Erasmus MC, Rotterdam, Holland
Monkeypox as a Model for Smallpox
Malik Peiris, University of Hong Kong, China
Pathogenesis and Origin of SARS
Martin L. Hibberd , Genome Institute of Singapore
Host Response to SARS
Tak-sun Ignatius Yu, The Chinese University of Hong Kong, China
Evidence on the Airborne Transmission of SARS
Jan H. ter Meulen, Crucell BV, Leiden, Holland
Monoclonal Antibodies to Treat SARS
Joe McCormack, University of Queensland, South Brisbane, Australia
Hendra virus in animals and humans
Jay W. Hooper, USAMRIID
Hantaviruses
Paul A. Rota, Centers for Disease Control, Atlanta, USA
Paramyxoviruses
Jian-Feng He?, Center for Disease Control and Prevention of Guangdong Province, China
Animal Reservoirs of Human Virus Infections
Peter M. Palese, Mount Sinai School of Medicine, New York, USA
Reverse Genetics of Influenza Viruses for Use in Vaccines
Yoshihiro Kawaoka, University of Wisconsin-Madison, USA
Influenza A (H5N1) Vaccines
Kanta Subbarao, National Institutes of Health, Bethesda, USA
Vaccines Against SARS Virus
* Stanley A. Plotkin, Sanofi Pasteur, Pennsylvania, USA
Inactivated Influenza A (H5N1) Vaccine
Rino Rappuoli, Chiron Srl, Siena, Italy
SARS and H5N1 Vaccines
James Young , MedImmune, Gaithersburg, USA
Live Influenza A (H5N1) Vaccine
Margaret Chen?, World Health Organization, Geneva, Switzerland
Plans for Control of Influenza A (H5N1)
Alejandro Schudel, Office Internatinal Des Epizooties, Paris, France
Vaccination of Animals to Control of Zoonotic Infections
Andrea Gambotto, University of Pittsburgh
Hildegund C.J. Ertl, Wistar Institute, Philadelphia, USA
Non-Human Adenoviruses
Peter Daszak, Consortium for Conservation Medicine, New York, USA
Ecological Control of Viral Zoonoses
